Brand Name
Zokinvy
Generic Name
Lonafarnib
View Brand Information FDA approval date: July 02, 2025
Classification: Farnesyltransferase Inhibitor
Form: Capsule
What is Zokinvy (Lonafarnib)?
ZOKINVY is indicated in patients 12 months of age and older with a body surface area of.
Approved To Treat
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment